Apoptosis in acquired and genetic hearing impairment: The programmed death of the hair cell

od de Beeck, Ken Op, Schacht, Jochen, Van Camp, Guy
Wydane 2011

Krüppel-like factors in cancer progression: three fingers on the steering wheel

od Limame, Ridha, de Beeck, Ken Op, Lardon, Filip, Wever, Olivier De, Pauwels, Patrick
Wydane 2013

DFNA5 promoter methylation a marker for breast tumorigenesis

od Croes, Lieselot, de Beeck, Ken Op, Pauwels, Patrick, Berghe, Wim Vanden, Peeters, Marc, Fransen, Erik, Camp, Guy Van
Wydane w Oncotarget (2017)

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor

od Boeckx, Carolien, Blockx, Lina, de Beeck, Ken Op, Limame, Ridha, Camp, Guy Van, Peeters, Marc, Vermorken, Jan B, Specenier, Pol, Wouters, An, Baay, Marc, Lardon, Filip
Wydane w Am J Cancer Res (2015)

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein

od de Beeck, Ken Op, Van Camp, Guy, Thys, Sofie, Cools, Nathalie, Callebaut, Isabelle, Vrijens, Karen, Van Nassauw, Luc, Van Tendeloo, Viggo FI, Timmermans, Jean Pierre, Van Laer, Lut
Wydane 2011

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in...

od Limame, Ridha, de Beeck, Ken Op, Van Laere, Steven, Croes, Lieselot, De Wilde, Annemieke, Dirix, Luc, Van Camp, Guy, Peeters, Marc, De Wever, Olivier, Lardon, Filip, Pauwels, Patrick
Wydane w Oncoscience (2013)

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

od Deben, Christophe, Wouters, An, de Beeck, Ken Op, van Den Bossche, Jolien, Jacobs, Julie, Zwaenepoel, Karen, Peeters, Marc, Van Meerbeeck, Jan, Lardon, Filip, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Wydane w Oncotarget (2015)

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

od Vandamme, Timon, Beyens, Matthias, de Beeck, Ken Op, Dogan, Fadime, van Koetsveld, Peter M, Pauwels, Patrick, Mortier, Geert, Vangestel, Christel, de Herder, Wouter, Van Camp, Guy, Peeters, Marc, Hofland, Leo J
Wydane w Br J Cancer (2016)